AstraZeneca plc vs Opendoor Technologies Inc — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Opendoor Technologies Inc trades at $3.6 (market cap $3.36B). The key difference: AstraZeneca plc is far larger — about 74.7× Opendoor Technologies Inc's market cap, and AstraZeneca plc pays a 1.97% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| AZN | OPEN | |
|---|---|---|
Market Cap | $250.84B | $3.36B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $10.52 |
52-Week Low | $147.06 | $2.42 |
Enterprise Value | $278.12B | $4.43B |
Dividend Yield | 1.97% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →